vTv Therapeutics
vTv Therapeutics

Dividends • vTv Therapeutics

VTVT

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
4/18/2024
5/3/2024
0,26
Quarterly
1/18/2024
2/2/2024
0,26
Quarterly
10/19/2023
11/3/2023
0,26
Quarterly
8/18/2023
9/5/2023
0,09
Quarterly
7/20/2023
8/4/2023
0,26
Quarterly
5/22/2023
6/6/2023
0,09
Quarterly
4/20/2023
5/5/2023
0,26
Quarterly
3/6/2023
-
0,09
Quarterly
1/19/2023
2/3/2023
0,26
Quarterly